# An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)

> **NCT00636961** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 27 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Indacaterol 300μg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00636961
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2011-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00636961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00636961, "An Exploratory Study, to Assess the Effect of Repeat-dose Inhaled Indacaterol Maleate (300 μg) on Dynamic and Static Lung Hyperinflation, Subjective Breathlessness and Health Status in Patients With Chronic Obstructive Pulmonary Disease(COPD)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00636961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*